On March 13, the NMN (Nicotinamide Mononucleotide) sector experienced a strong surge during trading. As of press time, Xuerong Bio, Baihe Co., Ltd., and Dezhan Health hit the daily limit, while Yaben Chemical rose over 10%, Meibang Technology gained nearly 8%, and Erkang Pharmaceutical and Chenguang Biotech increased by around 4%. By the market close, the NMN sector had risen 1.48%, ranking 6th among the top-gaining concept sectors.
According to the latest report from QYResearch, titled “Global Nicotinamide Mononucleotide (NMN) Market Report 2024-2030”, the global NMN market is projected to reach $890 million by 2030, with a compound annual growth rate (CAGR) of 13.3% over the next few years. (Source: Securities Times)
Sign Up to Receive China Updates Weekly Newsletter for FREE, HERE
Visit HPA-China’s Information Hub, HERE